Targeting Neuropathologies with GSK33 Inhibitor Larry H. Bernstein, MD, FCAP, Curator LPBI New 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors in Model of Mood Disorders by DR ANTHONY MELVIN CRASTO Ph.D CAS 1452582-16-9, 428.47, C23 H26 F2 N4 O2 1H-Indazole-3-carboxamide, 5-(2,3-difluorophenyl)-N-[[1-(2-methoxyethyl)-4-piperidinyl]methyl]- Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1 H-indazole-3-carboxamide compounds acting as glycogen synthase […]![]()
